OBJECTIVE To evaluate the incidence and risk factors for severe neutropenia in breast cancer patients receiving taxanes and epirubicin(TE)combination chemotherapy.METHODS Retrospective analysis was performed for breast cancer patients receiving TE combination regimen for neoadjuvant or systemic chemotherapy from2014 to 2015 in Tianjin Medical University Cancer Institute and Hospital.Patients' data of physiology,pathology,medications and the results of neutropenia were collected,and risk factors of severe ne...
【基金】
天津医科大学肿瘤医院药检放专项基金(编号:Y1404)
【更新日期】
2018-01-31
【分类号】
R737.9
【正文快照】
张超,王晨,王忱,高宁,缪玮,宋晓坤(天津医科大学肿瘤医院,国家肿瘤临床医学研究中心,天津市“肿瘤防治”重点实验室,天津市恶性肿瘤临床医学研究中心,天津300060)化疗是治疗乳腺癌的主要手段之一,紫杉类与蒽环类药物是乳腺癌化疗的“基石”,两药联合方案(taxanes and anthracyc